All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EXAC / Exactech, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
TBRA / Tobira Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
CASM / CAS Medical Systems, Inc.
|
|
|
|
|
|
|
|
ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AGTC / Applied Genetic Technologies Corp
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
ZSPH / ZS Pharma, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
IRONWOOD PHARMA
/ NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV (46333XAC2) |
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
87611RAA6 / Targacept Inc Bond
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
45784PAD3 / Insulet Corp. Bond
|
|
|
|
|
|
|
|
LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
CDNA / CareDx, Inc
|
|
|
|
|
|
|
|
CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
670704AC9 / NuVasive, Inc. Bond
|
|
|
|
|
|
|
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
LMNS / Lumenis Ltd
|
|
|
|
|
|
|
|
RIOT / Riot Platforms, Inc.
|
|
|
|
|
|
|
|
XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
|
|
|
|
|
CEMI / Chembio Diagnostics Inc.
|
|
|
|
|
|
|
|
DXTR / Dextera Surgical Inc.
|
|
|
|
|
|
|
|
ELOS / Syneron Medical Ltd.
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTR / LadRx Corp
|
|
|
|
|
|
|
|
29266SAB2 / Endologix, Inc. Bond
|
|
|
|
|
|
|
|
CHEK / Check-Cap Ltd.
|
|
|
|
|
|
|
|
IL0011177958 / Intec Pharma Ltd
|
|
|
|
|
|
|
|
VSCI /
|
|
|
|
|
|
|
|
SKYE / Skye Bioscience, Inc.
|
|
|
|
|
|
|
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
|
|
|
|
|
CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
US0906721065 / BioTelemetry, Inc.
|
|
|
|
|
|
|
|
SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
CYAD / Celyad Oncology - ADR
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
CHEK / Check-Cap Ltd.
|
|
|
|
|
|
|
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
RSLS / ReShape Lifesciences Inc.
|
|
|
|
|
|
|
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
|
|
|
|
|
VTVT / vTv Therapeutics Inc.
|
|
|
|
|
|
|
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
CARA / Cara Therapeutics, Inc.
|
|
|
|
|
|
|
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CVM / CEL-SCI Corporation
|
|
|
|
|
|
|
|
ATNM / Actinium Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|
PODD / Insulet Corporation
|
|
|
|
|
|
|
|
TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|